TAS2R43 IDG GPCR ARCHS4 coexpression (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with TAS2R43 IDG GPCR ARCHS4 coexpression.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with TAS2R43 IDG GPCR ARCHS4 coexpression.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with TAS2R43 IDG GPCR ARCHS4 coexpression.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with TAS2R43 IDG GPCR ARCHS4 coexpression.

Results found

Linked to

 

Label

Description

 

Gene

zinc finger protein 542, pseudogene

Gene

RRN3 pseudogene 1

Gene

SMG1 pseudogene 3

Gene

SMG1 pseudogene 1

Gene

protocadherin beta 17 pseudogene

Gene

FERM and PDZ domain containing 2B (pseudogene)

Gene

transmembrane protein 14E, pseudogene

Gene

actin gamma 1 pseudogene 22

Gene

vomeronasal 1 receptor 108 pseudogene

Gene

chaperonin containing TCP1 subunit 7 pseudogene 2

  • Gene

    zinc finger protein 542, pseudogene


  • Gene

    RRN3 pseudogene 1


  • Gene

    SMG1 pseudogene 3


  • Gene

    SMG1 pseudogene 1


  • Gene

    protocadherin beta 17 pseudogene


  • Gene

    FERM and PDZ domain containing 2B (pseudogene)


  • Gene

    transmembrane protein 14E, pseudogene


  • Gene

    actin gamma 1 pseudogene 22


  • Gene

    vomeronasal 1 receptor 108 pseudogene


  • Gene

    chaperonin containing TCP1 subunit 7 pseudogene 2

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.